CytomX Therapeutics
CTMX
CTMX
141 hedge funds and large institutions have $843M invested in CytomX Therapeutics in 2018 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 42 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
+22
Holders Change %
+18.49%
% of All Funds
3.24%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
39
Increased
42
Reduced
43
Closed
15
Calls
$2.72M
Puts
$177K
Net Calls
+$2.55M
Net Calls Change
+$2.58M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$81.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
$11.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$41.6M |
| 4 |
Renaissance Technologies
New York
|
$27.3M |
| 5 |
PC
PointState Capital
New York
|
$4.38M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Pacer Advisors
Malvern,
Pennsylvania
| – | -$11K | -525 | Closed |
|
|
CG
152
Cutler Group
San Francisco,
California
| – | -$10K | -500 | Closed |
|
153
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$6K | -307 | Closed |
|
154
Group One Trading
Chicago,
Illinois
| – | -$6K | -300 | Closed |
|
|
II
155
Inspire Investing
Meridian,
Idaho
| – | -$1K | -58 | Closed |
|